Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes.
|
Feb 2017
|
Blood Cancer J
|
myelodysplastic syndromes (MDS)
|
Management of lower-risk myelodysplastic syndromes without del5q: Current approach and future trends
|
Feb 2017
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.
|
Feb 2017
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Myelodysplastic Syndromes and Iron Chelation Therapy
|
Mar 2017
|
Mediterr J Hematol Infect Dis
|
myelodysplastic syndromes (MDS)
|
Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide
|
Mar 2017
|
Ther Adv Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Use of eltrombopag for treatment of myelodysplastic syndromes
|
Mar 2017
|
Lancet Haematol
|
myelodysplastic syndromes (MDS)
|
Molecular features of early onset adult myelodysplastic syndrome
|
Mar 2017
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome
|
Mar 2017
|
PLoS One
|
myelodysplastic syndromes (MDS)
|
Focal Adhesion Kinase as a Potential Target in AML and MDS
|
Mar 2017
|
Mol Cancer Ther
|
myelodysplastic syndromes (MDS)
|
Self-reported sleep disturbance and survival in myelodysplastic syndromes
|
Mar 2017
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|